Cleared Traditional

K864131 - VISION(TM) CRP

K864131 is an FDA 510(k) clearance for VISION(TM) CRP, manufactured by Abbott Laboratories. The device is a Class 2 Immunology device with product code DCK cleared through the Traditional 510(k) pathway after a 146-day FDA review.

K864131 · Abbott Laboratories · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1987
Decision
146d
Days
Class 2
Risk

K864131 is an FDA 510(k) clearance for the VISION(TM) CRP. Classified as C-reactive Protein, Antigen, Antiserum, And Control (product code DCK), Class II - Special Controls.

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on March 16, 1987 after a review of 146 days - within the typical 510(k) review window.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5270 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all Abbott Laboratories devices

FDA 510(k) Submission Details - K864131

510(k) Number K864131 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 21, 1986
Decision Date March 16, 1987
Days to Decision 146 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
42d slower than avg
Panel avg: 104d · This submission: 146d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DCK Device Classification - Class 2, Special Controls

Product Code DCK C-reactive Protein, Antigen, Antiserum, And Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5270
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DCK C-reactive Protein, Antigen, Antiserum, And Control

All 88
Devices cleared under the same product code (DCK) and FDA review panel - the closest regulatory comparables to K864131.
CRP
K873865 · Unipath , Ltd. · Oct 1987
TINA-QUANT [A] CRP
K871895 · Boehringer Mannheim Corp. · Jun 1987
PRECIMAT(R) CRP
K871055 · Boehringer Mannheim Corp. · May 1987
C-REACTIVE PROTEIN (CRP), FOR TECHNICON RA SYSTEMS
K863628 · Technicon Instruments Corp. · Oct 1986
ACA(R) C-REACTIVE PROTEIN (CRP) ANALYTICAL TEST
K863328 · E.I. Dupont DE Nemours & Co., Inc. · Sep 1986
ACA(R) C-REACTIVE PROTEIN (CRP) CALIBRATOR
K863329 · E.I. Dupont DE Nemours & Co., Inc. · Sep 1986